📈 நேரலை சந்தை கண்காணிப்பு

NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.

நேரலை இன்று 79 பகுப்பாய்வு செய்யப்பட்டது
பின்தொடர்Telegram
79
இன்று
168,780
இதுவரை பகுப்பாய்வு செய்யப்பட்டவை
49,911
நேர்மறை
8,497
எதிர்மறை
100,571
நடுநிலை
9,733
கண்காணி
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
அழி
62 அறிவிப்புகள் பொருந்தும் தாக்கம் 5+ Symbol: UGROCAP
நேர்மறை தாக்கம் 9/10 M&A

UGRO Capital Receives NSE/BSE No-Objection for Rs 3,468 Cr AUM Merger with Profectus Capital

UGRO Capital has received the 'No Objection' observation letters from both NSE and BSE for its proposed merger with Profectus Capital Private Limited (PCPL). This follows the earlier receipt of a No Objection certificate from the RBI in February 2026. The merger is a significant strategic move, as PCPL brings an AUM of Rs 3,468 Cr, which is substantial compared to UGRO's net worth of Rs 2,845 Cr. The company must now file the scheme with the NCLT within the next six months for final approval.

நடுநிலை தாக்கம் 6/10 வழக்கமானது

UGRO Capital Concludes 33rd AGM; Re-appoints Shachindra Nath as MD and Approves ESOPs

UGRO Capital held its 33rd Annual General Meeting on May 29, 2026, to approve the audited financial statements for the fiscal year ending March 31, 2026. Key management decisions included the re-appointment of Mr. Shachindra Nath as Vice Chairman and Managing Director and the appointment of M/s G.P. Kapadia & Co. as Statutory Auditors. The company also sought approval for variable compensation for the MD and the issuance of ESOPs to subsidiary employees under the 2022 scheme. Voting results will be disclosed separately following the scrutinizer's report.

நடுநிலை தாக்கம் 7/10 நிர்வாகம்

UGRO Capital Clarifies MD Pay: Proposed ₹10 Cr Package Below Market Median

UGRO Capital has issued a detailed clarification following a media report regarding proxy advisory concerns over MD Shachindra Nath's compensation. The company asserts that the proposed ₹10 crore package (₹7 crore fixed and ₹3 crore deferred) is at or below the market median according to an independent Aon study. A critical distinction is that Mr. Nath, as a promoter by law, is ineligible for ESOPs and SARs, unlike his peers whose total compensation includes significant equity components. The board also highlighted that Mr. Nath has personally guaranteed ₹1,830 crore of company debt without charging any commission.

நேர்மறை தாக்கம் 7/10 நிதி திரட்டல்

UGRO Capital Allots Secured NCDs Worth INR 200 Crores at 9.75% Coupon

UGRO Capital has approved the allotment of 2,00,000 senior secured Non-Convertible Debentures (NCDs) totaling INR 200 crores through a private placement. These NCDs carry a coupon rate of 9.75% per annum, which will be paid out on a monthly basis. The instrument has a relatively short tenure of 18 months, with a maturity date set for November 26, 2027. This capital infusion will likely be utilized to expand the company's lending book and manage liquidity.

நேர்மறை தாக்கம் 7/10 நிர்வாகம்

UGRO Capital to Re-appoint Shachindra Nath as MD for 5 Years; AGM Set for May 29, 2026

UGRO Capital has issued a notice for its 33rd Annual General Meeting (AGM) scheduled for May 29, 2026. The primary agenda includes the re-appointment of Mr. Shachindra Nath as Vice Chairman and Managing Director for a five-year term with a proposed total fixed compensation of ₹10 Crores for FY 2026-27. The notice highlights the MD's significant 'skin-in-the-game,' including personal guarantees of ₹1,830 Crores provided to lenders and a personal equity investment of ₹40 Crores. Other routine matters include the appointment of M/s G.P. Kapadia & Co. as Statutory Auditors.

📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்

நேர்மறைஎதிர்மறைநடுநிலைகவனம்
நடுநிலை தாக்கம் 6/10 நிர்வாகம்

UGRO Capital Appoints Satyabrata Mohapatra as COO Following Sharad Agarwal's Resignation

UGRO Capital has announced a transition in its senior leadership with the resignation of Mr. Sharad Agarwal, the Chief Operations & Technology Officer, effective May 5, 2026. To ensure continuity, the company has promoted Mr. Satyabrata Mohapatra, an internal candidate with over 4 years of experience at the firm, to the role of Chief Operations Officer. Mr. Mohapatra brings 20 years of total industry experience, having previously managed critical functions like co-lending and treasury operations. This internal promotion aims to maintain the company's growth trajectory and operational stability.

நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

UGRO Capital Q4 FY26: Net Total Income Up 51% YoY; Targets INR 220 Cr Annual Cost Savings

UGRO Capital reported a 51% YoY growth in Net Total Income for Q4 FY26, driven by a strategic shift towards high-yield Emerging Market LAP and Embedded Finance. The company is executing a major realignment to exit low-yield intermediated books, targeting INR 220 crore in annualized cost savings by FY27. While AUM remained flat QoQ due to the intentional run-down of non-focus segments, focus verticals now comprise 38% of the total book. Management maintains a healthy capital adequacy of 21.2% and expects to reach a 3-3.5% ROA by FY29 without further equity dilution.

நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

UGRO Capital Q4'FY26: PAT Grows 26% YoY to ₹51.1 Cr; Focus Vertical AUM Hits 38%

UGRO Capital reported a 26% YoY increase in PAT to ₹51.1 Cr for Q4'FY26, driven by a strategic shift toward high-yield focus verticals which now constitute 38% of AUM. The company is executing a cost rationalization plan following the Profectus consolidation, targeting annualized savings of ₹200-220 Cr. Capital Adequacy improved to 21.2%, supporting management's commitment to avoid incremental equity raises for the next three years. While GNPA rose slightly to 2.5% due to a marginal decline in total AUM, the transition to an annuity-led ROA model remains on track.

நேர்மறை தாக்கம் 8/10 BOARD_MEETING

Ugro Capital FY26 Revenue Up 26.5%, Plans ₹3,000 Cr NCD Fundraise & Re-appoints MD

Ugro Capital reported a strong financial performance for FY26, with total revenue rising to ₹1,766.24 crore from ₹1,395.90 crore in FY25. The Board has approved a significant fundraise of up to ₹3,000 crore through Non-Convertible Debentures (NCDs) to support its lending operations. Key leadership stability is ensured with the re-appointment of Mr. Shachindra Nath as MD for a five-year term. Additionally, the company is transitioning its statutory auditors to M/s G.P. Kapadia & Co. starting from the upcoming AGM.

நேர்மறை தாக்கம் 7/10 நிதி திரட்டல்

UGRO Capital Allots USD 20 Million Senior Secured Foreign Currency Bonds

UGRO Capital has successfully approved the allotment of USD 20 million in senior, secured, non-convertible foreign currency bonds through a private placement. The bonds carry a coupon rate of 300 basis points over Term SOFR and have a total tenure of 48 months. This fundraise, to be listed on the India International Exchange IFSC, demonstrates the company's ability to access international capital markets. The proceeds are expected to support the company's specialized lending operations in the SME sector.

நேர்மறை தாக்கம் 7/10 நிதி திரட்டல்

UGRO Capital Allots NCDs Worth ₹181.10 Crore via Private Placement

UGRO Capital has approved the allotment of two series of Non-Convertible Debentures (NCDs) totaling ₹181.10 crores. Series I consists of ₹46.10 crores in subordinated unsecured debt with a high coupon rate of 13.25% and a 6-year tenure. Series II involves ₹135 crores in senior secured debt at a 9.50% interest rate with a shorter tenure of approximately 13 months. This capital infusion is intended to support the company's lending operations and growth in the MSME sector.

நேர்மறை தாக்கம் 7/10 நிதி திரட்டல்

UGRO Capital to Raise Up to ₹205 Crore via Private Placement of NCDs

UGRO Capital's Investment and Borrowing Committee has approved the issuance of Non-Convertible Debentures (NCDs) totaling up to ₹205 crores. The fundraise is split into ₹155 crores of secured NCDs and ₹50 crores of unsecured subordinated NCDs. The secured portion carries a 9.50% monthly coupon with a short tenure of approximately 13 months, while the subordinated debt offers a 13.25% semi-annual coupon over 72 months. This capital infusion is aimed at strengthening the company's lending capacity and supporting its growth trajectory in the MSME sector.

நடுநிலை தாக்கம் 6/10 நிதி திரட்டல்

UGRO Capital Board to Meet on March 21 to Consider Fundraise via NCDs

UGRO Capital has scheduled a meeting of its Investment and Borrowing Committee for March 21, 2026, to discuss raising capital. The company intends to issue Non-Convertible Debentures (NCDs) through a private placement basis. This is a routine but essential activity for an NBFC to fuel its lending growth and manage liquidity. The specific quantum of the fundraise and the interest rates will be finalized during the upcoming committee meeting.

நேர்மறை தாக்கம் 6/10 நிதி திரட்டல்

UGRO Capital Allots Secured NCDs Worth ₹45 Crore at 9.50% Interest

UGRO Capital has approved the allotment of 45,000 secured, non-convertible debentures (NCDs) to raise ₹45 crore through a private placement. These instruments carry a coupon rate of 9.50% per annum, with interest payable on a monthly basis. The NCDs have a short-term tenure of 13 months, maturing on April 18, 2027. This capital raise will likely be utilized to support the company's ongoing lending operations and strengthen its liquidity position.

நேர்மறை தாக்கம் 8/10 நிதி திரட்டல்

UGRO Capital to Raise Over ₹530 Crores via NCDs and USD Denominated Bonds

UGRO Capital has approved the issuance of multiple debt instruments on a private placement basis to bolster its capital position. The fundraise includes domestic senior secured NCDs worth ₹300 crores and subordinated unsecured NCDs worth ₹65 crores with tenures up to 72 months. Additionally, the company is tapping international markets for USD 20 million (approx. ₹167 crores) through External Commercial Borrowings (ECBs). This diversified borrowing strategy aims to provide long-term liquidity and support the company's MSME lending growth.

நேர்மறை தாக்கம் 7/10 நிதி திரட்டல்

UGRO Capital Board to Meet on March 11 to Approve Fundraise via NCDs

UGRO Capital's Investment and Borrowing Committee is scheduled to meet on March 11, 2026, to consider a fundraise. The company plans to issue Non-Convertible Debentures (NCDs) or Bonds through a private placement. This capital infusion is intended to support the company's lending business and growth objectives. The specific amount and terms of the issuance will be determined during the upcoming committee meeting.

நேர்மறை தாக்கம் 8/10 M&A

UGRO Capital Revises MyShubhLife Acquisition to INR 38.23 Cr All-Cash Deal

UGRO Capital has amended its agreement to acquire 100% of Datasigns Technologies (MyShubhLife), shifting from a mixed cash-and-stock deal to an all-cash transaction. The total consideration has been reduced to INR 38.23 crores from the previously announced INR 45 crores, effectively preventing equity dilution for existing shareholders. The MyShubhLife platform is already deeply integrated, having facilitated an AUM of approximately INR 1,720 crores as of December 31, 2025. This acquisition solidifies UGRO's embedded finance ecosystem and digital MSME lending capabilities.

நேர்மறை தாக்கம் 8/10 M&A

UGRO Capital Receives RBI No-Objection for Merger with Subsidiary Profectus Capital

UGRO Capital has secured a 'No Objection' from the Reserve Bank of India (RBI) for the amalgamation of its wholly-owned subsidiary, Profectus Capital Private Limited, into itself. This regulatory clearance, received on February 25, 2026, follows the board's approval of the scheme on January 8, 2026. The merger is intended to simplify the organizational structure and integrate business operations. The process now moves toward obtaining approvals from the National Company Law Tribunal (NCLT), stock exchanges, and relevant stakeholders.

நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

UGRO Capital Q3 FY26 Consolidated PAT Rises 23% to ₹46 Cr; AUM Hits ₹15,454 Cr

UGRO Capital reported a 40% YoY growth in consolidated AUM to ₹15,454 crores for Q3 FY26, significantly boosted by the Profectus acquisition. Consolidated PAT increased 23% YoY to ₹46 crores, while the company maintained stable asset quality with a Gross NPA of 2.2%. Management is implementing a ₹220 crore cost rationalization plan and pivoting towards high-yield emerging market LAP and embedded finance. This strategic shift aims to reduce dependence on co-lending income and build a more predictable annuity-led interest income profile.

நடுநிலை தாக்கம் 7/10 நிதி முடிவுகள்

UGRO Capital Clarifies Q3 Standalone PAT Decline; Consolidated PAT Robust at ₹46.27 Crore

UGRO Capital issued a clarification regarding its Q3 FY26 standalone Profit After Tax (PAT), which dropped significantly to ₹6.38 crore from ₹43.31 crore in the previous quarter. The company explained that this decline was due to Direct Assignment (DA) transactions being executed through its subsidiary, Profectus Capital, to capture better pricing. Consequently, the consolidated PAT for the quarter remained strong at ₹46.27 crore. Management emphasizes that consolidated financials provide the only accurate view of the company's performance and underlying profitability.

⚠️ இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்